2015 Annual Meeting | 7HC.002 - Multiple Sclerosis Therapy I: Symptom Management

Date Friday 04/24/15

Time 08:00 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Barbara S. Giesser, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to: diagnose and treat primary and secondary fatigue in persons with MS, recognize common sleep disorders in persons with MS, screen for and manage depression and cognitive dysfunction in persons with MS, elicit a history of genitourinary dysfunction and treat, and be able to describe a comprehensive approach to disorders of mobility in persons with MS. Additionally, participants will be able to counsel patients upon lifestyle choices that may improve their symptoms and ability to function.

CME Available 3.75 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
08:00 AM - 08:05 AM		Introduction Barbara S. Giesser, MD, FAAN
08:05 AM - 08:35 AM		Wellness and Lifestyle Strategies Barbara S. Giesser, MD, FAAN
08:35 AM - 08:40 AM		Questions and Answers
08:40 AM - 09:20 AM		Fatigue and Sleep Disorders Jonathan L. Carter, MD
09:20 AM - 09:25 AM		Questions and Answers
09:25 AM - 10:05 AM		Depression and Cognitive Dysfunction Michelle Cameron, MD
10:05 AM - 10:10 AM		Questions and Answers
10:10 AM - 10:25 AM		Break
10:25 AM - 11:05 AM		Neurogenic Bladder and Bowel Elizabeth Crabtree-Hartman, MD
11:05 AM - 11:10 AM		Questions and Answers
11:10 AM - 11:50 AM		Symptoms Affecting Mobility Andrew K. Dorsch, MD
11:50 AM - 12:00 PM		Questions and Answers

Faculty Disclosures
Barbara S. Giesser, MD, FAAN	Dr. Giesser has received publishing royalties from a publication relating to health care. Dr. Giesser has a non-compensated relationship as a advisory committee member with National MS Society that is relevant to AAN interests or activities.
Jonathan L. Carter, MD	Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Andrew K. Dorsch, MD	No disclosure on file
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��